Literature DB >> 23404473

VRE transmission via the reusable breathing circuit of a transport ventilator: outbreak analysis and experimental study of surface disinfection.

Sebastian Schulz-Stübner, Antje Schmidt-Warnecke, Jae-Hyuk Hwang.   

Abstract

Mesh:

Substances:

Year:  2013        PMID: 23404473     DOI: 10.1007/s00134-013-2842-y

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  3 in total

1.  Transmission of extended-spectrum β-lactamase Klebsiella oxytoca via the breathing circuit of a transport ventilator: root cause analysis and infection control recommendations.

Authors:  S Schulz-Stübner; E Kniehl
Journal:  Infect Control Hosp Epidemiol       Date:  2011-08       Impact factor: 3.254

2.  Clinical prediction rule for identifying patients with vancomycin-resistant enterococci (VRE) at the time of admission to the intensive care unit in a low VRE prevalence setting.

Authors:  Young Kyung Yoon; Hyeon Jeong Kim; Won Jin Lee; Sung Eun Lee; Kyung Sook Yang; Dae Won Park; Jang Wook Sohn; Min Ja Kim
Journal:  J Antimicrob Chemother       Date:  2012-08-10       Impact factor: 5.790

3.  Microbiological safety and cost-effectiveness of weekly breathing circuit changes in combination with heat moisture exchange filters: a prospective longitudinal clinical survey.

Authors:  Nils-Olaf Hübner; Georg Daeschlein; Christian Lehmann; Sergei Musatkin; Ute Kohlheim; Andreas Gibb; Ojan Assadian; Hiroyoshi Kobayashi
Journal:  GMS Krankenhhyg Interdiszip       Date:  2011-12-15
  3 in total
  1 in total

1.  Epidemiological and genetic characteristics of vancomycin-resistant Enterococcus faecium isolates in a University Children's Hospital in Germany: 2019 to 2020.

Authors:  Ilona Trautmannsberger; Laura Kolberg; Melanie Meyer-Buehn; Johannes Huebner; Guido Werner; Robert Weber; Valerie Heselich; Sebastian Schroepf; Hans-Georg Muench; Ulrich von Both
Journal:  Antimicrob Resist Infect Control       Date:  2022-03-12       Impact factor: 4.887

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.